Health and service promotor / Investment fund - Investor / Property management
Last update November 30, 2022 | Report an error
Already a subscriber? Login
Chief Executive Officer
Chief Executive Officer
After completing its first French acquisition in Villejuif at the end of 2022, Kadans Sciences Partners announced in mid-February its second French project, this (...)
BiTV Interviews welcomes Michel Leemhuis, CEO and Co-owner at Kadans Science Partner. With him, we discuss the new 70,000 sqm building in London developped by his (...)
Paris-based global manager AXA IM Alts has raised €1.9bn of equity to accelerate investments into the Life Sciences sector. The capital raised will primarily (...)
Bought buy Axa IM Alts last autumn, Kadans Science Partner, has added The Sherard Building on Oxford Science Park, UK to its Pan-European portfolio. (...)
AXA Investment Managers announces a 6% increase in underlying earnings to €279m in 2020, driven by higher revenues. Revenues increased by 4% to €1,294m, (...)
Following its October $14.6bn recapitalisation of BioMed Realty, the largest private owner of life science office buildings in the United States, Blackstone announced in (...)
AXA Investment Managers - Real Assets has agreed to acquire, on behalf of clients, Kadans Science Partner, a fully integrated developer, owner and operator (...)